ReviewClinical endoscopy2017
Clinical and Biological Features of Interval Colorectal Cancer.
Review in Clinical endoscopy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed.
- Patient-derived organoids for precision oncology in colorectal cancer: from tumor modeling to clinical translation.Molecular cancer · 2026Review
- Article
- The Impact of Age on Preferences for Colorectal Cancer Surveillance Strategies: Are Fecal Immunochemical Tests FIT for Surveillance?Cancer medicine · 2025Article
- Immunohistochemical insights into the pathogenesis of colonic sessile serrated lesions.Archive of clinical cases · 2025Article
- Clinicopathological and molecular differences between stage IV screen-detected and interval colorectal cancers in the Flemish screening program.Frontiers in oncology · 2024Article
- Improved use of faecal immunochemical tests for haemoglobin in the Scottish bowel screening programme.Journal of medical screening · 2023Article
- Postcolonoscopy Colorectal Cancer in a Referral Center for Colorectal Cancer: Prevalence and Risk Factors.GE Portuguese journal of gastroenterology · 2023Article
- Sessile serrated lesions with dysplasia: is it possible to nip them in the bud?Journal of gastroenterology · 2023Review
- Most large colorectal polyps missed by gastroenterology fellows at colonoscopy are sessile serrated lesions.Endoscopy international open · 2022Article
- Weakly Supervised Polyp Segmentation in Colonoscopy Images Using Deep Neural Networks.Journal of imaging · 2022Article
- Article
- Rate of detection of serrated lesions at colonoscopy in an average-risk population: a meta-analysis of 129,001 individuals.Endoscopy international open · 2021Article
- Serrated Colorectal Cancer: The Road Less Travelled?Trends in cancer · 2019Review
- Prevalence of 'one and done' in adenoma detection rates: results from the New Hampshire Colonoscopy Registry.Endoscopy international open · 2019Article
- DNA methylation changes that precede onset of dysplasia in advanced sessile serrated adenomas.Clinical epigenetics · 2019Article
- Rate of missed oesophageal cancer at routine endoscopy and survival outcomes: A multicentric cohort study.United European gastroenterology journal · 2019Article
- Implementing visual cues to improve the efficacy of screening colonoscopy: exploiting the Hawthorne effect.Annals of gastroenterologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Interval colorectal cancer (I-CRC) is defined as a CRC diagnosed within 60 months after a negative colonoscopy, taking into account that 5 years is the "mean sojourn time." It is important to prevent the development of interval cancer. The development of interval colon cancer is associated with female sex, old age, family history of CRC, comorbidities, diverticulosis, and the skill of the endoscopist. During carcinogenesis, sessile serrated adenomas/polyps (SSA/Ps) share many genomic and colonic site characteristics with I-CRCs. The clinical and biological features of I-CRC should be elucidated to prevent the development of interval colon cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.